Mitoxantrone hydrochloride in lymphoma

Cancer Treatment Reviews - Tập 10 - Trang 73-76 - 1983
C.A. Coltman1, T.M. McDaniel1, S.P. Balcerzak1, F.S. Morrison1, D.D. Von Hoff1
1Section of Medical Oncology, Department of Medicine, University of Texas Health Sciences Center, San Antonio, TX 78316, U.S.A.

Tài liệu tham khảo

Aapro, 1982, Phase II Cardiotoxicity Study of Mitoxantrone Hydrochloride using Exercise Radionuclide Evaluation of the Left Ventricular Cardiac Ejection Fraction (LVEF), 1, 14 Coltman, 1983, Mitoxantrone Hydrochloride (NSC-310739) in Lymphoma, 1, 65 Dimarco, 1975, Adriamycin (NSC-123127) mode and mechanism of action, Cancer Chemother. Rep., 6, 91 Dorfman, 1983, A working formulation of non-Hodgkin's lymphomas: background, recommendations, histological criteria and relationship to other classifications, 351 Double, 1976, Evaluation of the binding of some anthraquinones and napthacenequinones to DNA, J. Pharm. Pharmacol., 28, 116, 10.1111/j.2042-7158.1976.tb04122.x Henderson, 1982, Safety assessment of a new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. I. Clinical Observations, Cancer Treat. Rep., 66, 1139 Schell, 1982, Potential cardiotoxicity observed with dihydroxyanthracenedione (DHAD) chemotherapy, 1, 21 Sparano, 1982, Safety assessment of a new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. II. Histologic and ultrastructural pathology, Cancer Treat. Rep., 66, 1145 Unverferth, 1982, Cardiac evaluation of aclacinomycin (ACLAC) and dihydroxyanthracenedione (DHAD), 23, 135 Von Hoff, 1981, Activity of mitoxantrone in a human tumor cloning system, Cancer Res., 41, 1853 Von Hoff, 1980, Phase I clinical investigation of 1,4-dihydroxy-5,8-bis(((2-((2-hydroxyethyl)-amino(ethyl(amino))-9, 10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione, Cancer Res., 40, 1516 Von Hoff, 1967, Daunomycin-induced cardiotoxicity in children and adults, Am. J. Med., 62, 200, 10.1016/0002-9343(77)90315-1 Von Hoff, 1978, Daunomycin: An anthracycline antibiotic effect in acute leukemia, Adv. Pharm. Chemother., 15, 1, 10.1016/S1054-3589(08)60480-9 Wallace, 1979, Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis (((2-((2-hydroxy-ethyl)amino))-9,10 anthracenedione dihydrochloride, against experimental tumors in mice, Cancer Res., 39, 1570